Position in XNCR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$163,919,284
+$39,242,739 QoQ
Shares Held
10,181,322
-1.5% QoQ
Ownership
13.7%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#2
of 208 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in XNCR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PRIMECAP MANAGEMENT CO/CA/ holds $3,557,107,452 across 15 Biotechnology names. XNCR ranks #5 (4.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ONC |
BeOne Medicines Ltd.
|
5,007,931 | $1,427,110,097 | |
| 2 | BMRN |
Biomarin Pharmaceutical Inc
|
14,190,183 | $811,962,271 | |
| 3 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
3,168,853 | $351,837,748 | |
| 4 | BNTX |
BioNTech SE
|
3,772,031 | $350,987,484 | |
| 5 | XNCR |
Xencor Inc
This page
|
10,181,322 | $163,919,284 | |
| 6 | IMCR |
Immunocore Holdings plc
|
3,638,241 | $115,514,151 | |
| 7 | IMNM |
Immunome Inc.
|
4,581,431 | $97,080,522 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,015,980 | $75,670,190 |
All Filings in XNCR
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $163,919,284 | 10,181,322 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $124,676,545 | 10,338,022 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $156,442,509 | 10,218,322 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $125,218,008 | 10,675,022 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $82,744,750 | 10,527,322 | Shares | Sole | 2025-08-14 | |
| 2025-06-30 | $82,744,750 | 10,527,322 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $103,857,167 | 9,761,012 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $206,462,247 | 8,984,432 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $183,748,991 | 9,137,195 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $172,569,703 | 9,116,202 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $201,177,345 | 9,090,707 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $188,981,116 | 8,901,607 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $164,911,750 | 8,184,206 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $193,538,774 | 7,750,852 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $210,927,021 | 7,562,819 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $161,888,154 | 6,216,903 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $147,832,201 | 5,690,231 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $131,240,573 | 4,795,052 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $131,842,208 | 4,941,612 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $200,111,418 | 4,987,822 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $172,308,673 | 5,275,832 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $182,682,217 | 5,296,672 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $228,765,809 | 5,312,722 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $233,002,611 | 5,340,422 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $209,781,440 | 5,408,132 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $179,080,164 | 5,528,872 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $170,327,115 | 5,700,372 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||